| Bioactivity | 3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine |
| CAS | 2095417-44-8 |
| Formula | C13H19N5O3 |
| Molar Mass | 293.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine
CAS: 2095417-44-8 F: C13H19N5O3 W: 293.32
3’-Deoxy-3’-α-C-methyl-N6,N6-dimethyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.